Logo image of ALVGO.PA

VOGO SACA (ALVGO.PA) Stock Fundamental Analysis

EPA:ALVGO - Euronext Paris - Matif - FR0011532225 - Common Stock - Currency: EUR

2.75  -0.02 (-0.72%)

Fundamental Rating

2

Overall ALVGO gets a fundamental rating of 2 out of 10. We evaluated ALVGO against 99 industry peers in the Software industry. Both the profitability and financial health of ALVGO have multiple concerns. ALVGO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALVGO had negative earnings in the past year.
In the past year ALVGO has reported a negative cash flow from operations.
ALVGO had negative earnings in each of the past 5 years.
ALVGO had a negative operating cash flow in each of the past 5 years.
ALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFALVGO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

ALVGO has a Return On Assets of -4.69%. This is in the lower half of the industry: ALVGO underperforms 63.64% of its industry peers.
ALVGO has a worse Return On Equity (-8.91%) than 62.63% of its industry peers.
Industry RankSector Rank
ROA -4.69%
ROE -8.91%
ROIC N/A
ROA(3y)-8.57%
ROA(5y)-11.8%
ROE(3y)-22.22%
ROE(5y)-27.53%
ROIC(3y)N/A
ROIC(5y)N/A
ALVGO.PA Yearly ROA, ROE, ROICALVGO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

With a Gross Margin value of 55.26%, ALVGO is not doing good in the industry: 65.66% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALVGO has grown nicely.
The Profit Margin and Operating Margin are not available for ALVGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y62.94%
GM growth 5YN/A
ALVGO.PA Yearly Profit, Operating, Gross MarginsALVGO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

ALVGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALVGO has more shares outstanding
Compared to 5 years ago, ALVGO has more shares outstanding
The debt/assets ratio for ALVGO has been reduced compared to a year ago.
ALVGO.PA Yearly Shares OutstandingALVGO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALVGO.PA Yearly Total Debt VS Total AssetsALVGO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that ALVGO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALVGO (1.22) is worse than 65.66% of its industry peers.
ALVGO has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALVGO (0.33) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACC7.69%
ALVGO.PA Yearly LT Debt VS Equity VS FCFALVGO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.70 indicates that ALVGO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.70, ALVGO is in the better half of the industry, outperforming 67.68% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that ALVGO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.88, ALVGO is doing worse than 71.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 0.88
ALVGO.PA Yearly Current Assets VS Current LiabilitesALVGO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.18% over the past year.
ALVGO shows a small growth in Revenue. In the last year, the Revenue has grown by 1.48%.
Measured over the past years, ALVGO shows a very strong growth in Revenue. The Revenue has been growing by 66.72% on average per year.
EPS 1Y (TTM)53.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.26%
Revenue 1Y (TTM)1.48%
Revenue growth 3Y19.96%
Revenue growth 5Y66.72%
Sales Q2Q%25.83%

3.2 Future

ALVGO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.74% yearly.
ALVGO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.35% yearly.
EPS Next Y72.4%
EPS Next 2Y42.39%
EPS Next 3Y30.74%
EPS Next 5YN/A
Revenue Next Year10%
Revenue Next 2Y22.47%
Revenue Next 3Y19.35%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALVGO.PA Yearly Revenue VS EstimatesALVGO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
ALVGO.PA Yearly EPS VS EstimatesALVGO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALVGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 266.99, the valuation of ALVGO can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVGO indicates a slightly more expensive valuation: ALVGO is more expensive than 66.67% of the companies listed in the same industry.
ALVGO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 266.99
ALVGO.PA Price Earnings VS Forward Price EarningsALVGO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

65.66% of the companies in the same industry are cheaper than ALVGO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 337.41
ALVGO.PA Per share dataALVGO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALVGO's earnings are expected to grow with 30.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.39%
EPS Next 3Y30.74%

More info and screens

0

5. Dividend

5.1 Amount

ALVGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VOGO SACA

EPA:ALVGO (3/7/2025, 7:00:00 PM)

2.75

-0.02 (-0.72%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)N/A N/A
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners27.13%
Ins Owner ChangeN/A
Market Cap16.86M
Analysts84
Price Target4.39 (59.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)28.57%
EPS NY rev (3m)28.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-15.38%
Revenue NY rev (3m)-15.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 266.99
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 6.03
EV/EBITDA 337.41
EPS(TTM)-0.23
EYN/A
EPS(NY)0.01
Fwd EY0.37%
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS1.76
BVpS2.13
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.69%
ROE -8.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.26%
FCFM N/A
ROA(3y)-8.57%
ROA(5y)-11.8%
ROE(3y)-22.22%
ROE(5y)-27.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y62.94%
GM growth 5YN/A
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 66.02
Cap/Depr 209.59%
Cap/Sales 24.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 0.88
Altman-Z 1.22
F-Score3
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)236.4%
Cap/Depr(5y)178.45%
Cap/Sales(3y)19.69%
Cap/Sales(5y)20.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.26%
EPS Next Y72.4%
EPS Next 2Y42.39%
EPS Next 3Y30.74%
EPS Next 5YN/A
Revenue 1Y (TTM)1.48%
Revenue growth 3Y19.96%
Revenue growth 5Y66.72%
Sales Q2Q%25.83%
Revenue Next Year10%
Revenue Next 2Y22.47%
Revenue Next 3Y19.35%
Revenue Next 5YN/A
EBIT growth 1Y47.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year166.67%
EBIT Next 3Y49.38%
EBIT Next 5YN/A
FCF growth 1Y-13.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.58%
OCF growth 3YN/A
OCF growth 5YN/A